Home › Gilead, Other Biotechs Selling Off On Market Weakness
 

Keywords :   


Gilead, Other Biotechs Selling Off On Market Weakness

2016-01-04 23:29:58| Biotech - Topix.net

Market mayhem continues, as Gilead Sciences, Inc. and other biotech companies are selling off on Monday's market weakness. Gilead Science's weekly performance is hovering around -5.75 percent and the issue has a YTD performance of -3.5 percent.

Tags: market selling weakness gilead

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05New ACA-Published Industry Market Analysis for the Paint & Coatings Industry Now Available
20.05Ulta Beauty Launches Same-Day Delivery with DoorDash
20.05Nivea Crmes Limited-Edition Pride Tin Heralds New Initiative with PFLAG
20.05Sheboygan Paint Company Appoints New Technical Sales Representative
20.05Scentair Adds Two Odor-Neutralizing Fragrances to its Auto Line Up
20.05GK Hair Unveils Summer 2024s Must-Have Hair Trends
20.05Revlon Taps Under Armour\'s Tchernavia Rocker As New Chief People Officer
20.05Canada invests over $9.6M to prevent, prepare for African swine fever
More »